Toficalm

Critical Warnings & Restrictions

Basic Toficalm Information

• INN (International Nonproprietary Name): Tofisopam.
• Brand Names Available In Australia: Toficalm (India; Tablets: 50mg, 100mg; Torrent Pharmaceuticals, Apple Pharma; Box of 10×10 tablets), Tofisign (India; Tablets: 100mg; A M Overseas; 10×10 strips/box), Tofifresh (India; Tablets: 100mg; Manufacturer not specified; 1×10 strip/box), Tofiso (India; Tablets: 50mg; Apple Pharmaceuticals; 10×10 tablets/box), TOFIZIN (India; Tablets: 50mg, 100mg; Neuracle Lifesciences; not specified), Nextril (India; Tablets: 100mg; Torrent Pharmaceuticals; not specified), Tofypeace (India; Tablets: 50mg; Psychocare Health Pvt. Ltd.; not specified), Emandaxin (Europe; Tablets: 50mg, 100mg; local/various; local packaging), Grandaxin (Europe, Russia, Turkey; Tablets: 50mg, 100mg; Egis, others; local packaging).
• ATC Code: N05BA23.
• Forms & Dosages: Tablet formulations are sold in 50mg and 100mg strengths, commonly supplied in blisters or boxes (10×10 tablets).
• Manufacturers In Australia: not specified.
• Registration Status In Australia: not specified.
• OTC / Rx Classification: Prescription Only (Rx) in regulated markets.

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

Worried about who should not use tofisopam and why?

Tofisopam can cause drowsiness and other central nervous system effects.

Absolute contraindications from product information include known hypersensitivity to tofisopam or any ingredient, severe respiratory insufficiency, sleep apnoea syndrome, acute intoxication with alcohol or other central nervous system depressants, and severe hepatic impairment.

Common side effects reported include drowsiness, nausea or other digestive upset, dizziness, headache and fatigue or weakness.

Patients in high‑risk groups need extra protection and monitoring.

• Checklist Before Supply:
• Confirm pregnancy and breastfeeding status.
• Ask about current alcohol use and recent use of recreational drugs or prescription sedatives.
• Screen for history of substance abuse.
• Check for known severe liver disease or current hepatic impairment.
• Confirm any respiratory conditions including sleep apnoea or COPD.

When pregnancy is a possibility, recommend pregnancy testing if clinically appropriate and discuss contraception for women of childbearing potential before starting therapy.

Practical Counselling

• Do not combine tofisopam with alcohol or other sedating medicines such as opioids, benzodiazepines or sedating antihistamines.
• Advise patients to take the dose exactly as prescribed and not to increase the dose without talking to the prescriber.
• Instruct on recognising overdose signs: severe drowsiness, confusion, slow or difficult breathing, inability to wake up.
• Overdose Action Checklist:
• If overdose suspected, call Triple Zero (000) for emergency medical help or go to the nearest emergency department immediately.
• Take the medicine pack or remaining tablets to hospital to help identify the product and dose.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Concerned about whether you can drive or work after taking the medicine?

Tofisopam can cause drowsiness and may impair alertness in some people.

Patients must be fit to drive and operate machinery and must meet legal fitness‑to‑drive requirements in Australia.

If drowsy, dizzy or otherwise impaired, do not drive or perform safety‑critical work.

Employers and workers in high‑risk roles such as heavy vehicle driving, mining, aviation, or other safety‑critical tasks should treat any sedative effect seriously and follow workplace policies about medication and fitness for duty.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: There is no guarantee that driving will be safe after taking tofisopam.

If you feel drowsy, dizzy or impaired do not drive.

Australian road laws require drivers to be unimpaired by drugs or alcohol.

Check with the prescriber or pharmacist before driving on a new dose or when starting therapy.

Usage Basics

INN, Brand Names And Availability

What are the common brand names and how is tofisopam supplied?

The international nonproprietary name is tofisopam and common international brands include Toficalm (India), Tofisign (India), Tofifresh (India), Tofiso (India), TOFIZIN (India), Nextril (India), Tofypeace (India), Emandaxin (Europe) and Grandaxin (Europe and some other markets).

Formulations are most commonly 50mg and 100mg tablets supplied in blister packs, for example boxes of 10×10 tablets.

Legal Classification (TGA Approval, PBS Listing)

What is the legal status and how to check current registration?

Tofisopam is classified as prescription‑only in regulated markets.

TGA registration and PBS listing can change over time and must be confirmed by clinicians and pharmacists via the TGA Australian Register of Therapeutic Goods (ARTG) and the PBS website.

Patient Note:

• Always obtain a lawful prescription before obtaining tofisopam.
• Avoid importing medicines from unverified overseas pharmacies because of regulatory and safety risks.
• Keep dispensing records and report suspected adverse reactions as part of pharmacovigilance.

Definitions

• INN: International Nonproprietary Name — the recognised non‑proprietary name of the medicine.
• ATC Code: N05BA23 — classification used for psycholeptics/anxiolytics.
• 2,3‑Benzodiazepine: Chemical class distinct from classic 1,4‑benzodiazepines.

Dosing Guide

Standard Regimens

How is tofisopam usually dosed for anxiety and related uses?

Typical adult dosing internationally is 50–100mg two to three times daily for anxiety, adjunctive depression therapy and as an adjunct in alcohol‑withdrawal management.

Treatment duration for anxiety or adjustment disorders is usually short‑term, commonly 2–6 weeks, with regular review to reduce the risk of dependence.

Because dosing varies by indication and patient factors, prescribers should tailor the regimen and document review plans.

Adjustments For Comorbidities

Who needs a lower starting dose or closer monitoring?

• Elderly: Start at the lowest effective dose and titrate slowly while monitoring for sedation, falls and cognitive changes.
• Liver or Kidney Impairment: Dose reduction may be necessary and slower titration is advised; consult a specialist if severe impairment is present.
• Children: Safety and efficacy have not been established and use is generally not recommended.
• History Of Substance Abuse: Use with caution and consider alternative treatments or specialist referral.

Q&A — “What If I Miss A Dose?”

Take the missed dose as soon as you remember unless it is almost time for the next scheduled dose.

Do not double up to make up for a missed dose.

If unsure, contact the pharmacist or prescriber for personalised advice.

When To Call The Prescriber

• Missed multiple doses.
• Severe side effects such as marked sedation or respiratory difficulty.
• Concerns about withdrawal or dependence with ongoing use.

Interaction Chart

Food And Drink Interactions (Alcohol, Caffeine, Australian Diet Context)

Will that Friday night drink or cup of coffee affect the medicine?

Avoid alcohol while taking tofisopam; acute intoxication with alcohol is an absolute contraindication.

Caffeine does not directly reverse sedation but can mask sedative effects and may lead people to underestimate impairment.

Practical tips for social settings and long weekends in Australia:

• Plan to avoid alcohol when starting a new dose or during dose changes.
• Be cautious at social events where alcohol is served; nominate a sober driver if uncertain.
• Use non‑alcoholic alternatives and discuss the timing of doses relative to evening plans to reduce night‑time sedation risk.

Common Drug Conflicts

Which medicines commonly interact with tofisopam?

Enzyme‑mediated interactions may be relevant with drugs that undergo extensive hepatic metabolism, so consult an interaction checker for complex regimens.

Safety tools recommended include the TGA online resources, MIMS and pharmacy interaction software.

Interaction Severity Levels

• Minor: unlikely to require action.
• Moderate: may require monitoring or dose change.
• Major: combination should be avoided if possible.

User Reports & Trends

What patients and search trends are saying about tofisopam?

Common search phrases seen internationally include “Toficalm 100 mg”, “Toficalm side effects”, “Tofisopam buy online India” and “Grandaxin Europe”.

Typical patient reports and concerns include perceived anxiolytic benefit with relatively less sedation than classic benzodiazepines, and worries about availability, price and risk of dependence.

• Reported Benefits: Anxiolysis with less motor impairment compared with some 1,4‑benzodiazepines.
• Reported Concerns: Cost, supply issues, dependence with prolonged use.

Clinicians should weigh anecdotal reports against clinical evidence and structured trial data when advising patients.

How To Gather Local Feedback

• Consult community pharmacist networks such as the Pharmacy Guild and local professional groups.
• Use anonymised ProductReview summaries and e‑pharmacy feedback cautiously.
• Collect GP and specialist anecdotal experience while maintaining patient confidentiality.

Access & Purchase Options

National Chains And Community Pharmacies

Where can Australians ask about lawful sourcing and alternatives?

Major Australian pharmacy chains to consult for advice include Chemist Warehouse, Priceline and TerryWhite Chemmart.

Stock availability depends on local wholesaler supply and TGA registration, so call ahead or check online stock listings.

• Pharmacy Query Checklist:
• Confirm whether the brand is held in stock or can be ordered.
• Ask the pharmacist about lawful alternatives listed on the PBS if cost is an issue.
• Confirm the need for a valid prescription.

Online Pharmacies And Telehealth E‑Prescriptions

Can tofisopam be obtained online in Australia?

E‑prescriptions from Australian prescribers via telehealth are accepted in Australia when using Australian‑registered pharmacies.

Importing prescription medicines from overseas has legal and safety risks and should be avoided unless authorised under TGA personal importation rules.

In our online pharmacy, toficalm is available without a prescription, with discreet delivery to Australia in 9-21 days.

Rural patients may face longer delays, so plan with the prescriber for contingency supplies and emergency supply protocols.

Mechanism & Pharmacology

Simplified Explanation For Patients

How does tofisopam work and how is it different to other benzodiazepines?

Tofisopam is a 2,3‑benzodiazepine derivative, chemically distinct from classic 1,4‑benzodiazepines.

It is classified under ATC code N05BA23 and tends to produce anxiolysis with less sedation and motor impairment than many 1,4‑benzodiazepines.

Clinical Terms For Prescribers

Clinicians should note that mechanistic details differ from classic benzodiazepines.

Effects on cognition and muscle relaxation are usually less pronounced, making tofisopam useful when anxiolysis is needed without heavy sedation.

Pharmacokinetic variability and hepatic metabolism mean caution is needed in hepatic impairment.

• Definitions
• INN: International Nonproprietary Name for the active substance.
• ATC: Anatomical Therapeutic Chemical code N05BA23 for classification.
• 2,3‑Benzodiazepine: Chemical subclass distinct from 1,4 variants often noted for different clinical profiles.

Indications & Off‑Label Uses

Approved Indications (International Context)

Where is tofisopam used clinically?

Internationally, tofisopam is used for anxiety disorders and has documented use as adjunctive therapy for depression and as an adjunct in alcohol‑withdrawal management.

Typical adult dosing in these indications is 50–100mg two to three times daily.

Off‑Label And Local Practice In Australia

Off‑label uses are possible in specialist settings but must be justified and documented.

If an indication is not TGA‑approved in Australia for tofisopam, clinicians should obtain informed consent, document the rationale and consider specialist referral where appropriate.

• Checklist For Off‑Label Use:
• Document clinical rationale and supporting evidence.
• Discuss risks, benefits and alternatives with the patient and obtain documented consent.
• Consider referral to psychiatry or addiction medicine when appropriate.

Key Clinical Findings

What does the clinical evidence say?

International studies suggest anxiolytic efficacy with relatively lower sedation compared with classic benzodiazepines, though high‑quality long‑term safety and dependence data are limited.

There are few recent high‑quality Australian randomised controlled trials specifically for tofisopam and clinicians should consult PubMed, Cochrane and TGA statements for up‑to‑date evidence.

Do not substitute literature searches for clinical judgement when treating individual patients.

Monitoring Checklist

• Review response and adverse effects within 1–2 weeks of starting.
• Monitor for sedation, falls and mood change.
• Assess for signs of misuse or dependence with ongoing therapy.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Pros And Cons Checklist

• Diazepam — Pros: rapid onset for acute severe anxiety; Cons: sedation, higher dependence risk.
• Alprazolam — Pros: effective for panic and anxiety; Cons: sedation and dependence concerns.
• Oxazepam — Pros: milder sedation in some patients; Cons: still a benzodiazepine with dependence potential.
• Buspirone — Pros: non‑sedating anxiolytic with low dependence risk; Cons: slower onset and variable efficacy for severe anxiety.

Decision aids should consider symptom severity, need to avoid sedation, comorbidity and PBS availability when selecting an alternative.

Common Questions

Short answers for typical pharmacy consultations.

• Does It Cause Dependence? — Dependence is possible with prolonged use; limit duration to the shortest effective period and monitor.
• Can Pregnant Or Breastfeeding Women Take It? — Use is contraindicated or should only occur if the prescriber judges benefits outweigh risks; consult an obstetrician or GP.
• What Are Common Side Effects? — Drowsiness, nausea, dizziness, headache and fatigue or weakness.
• Can I Mix With Antidepressants? — Some combinations are used clinically, for example as adjunctive treatment, but check interactions and monitor mood and sedation closely.

When To See The GP:

• Persistent or worsening anxiety despite treatment.
• Marked side effects or signs of misuse.

Price & Access Comparison

Comparison Table Guidance

Price and source affect patient choices.

Access Checklist For Patients

• Confirm lawful prescription.
• Verify Australian pharmacy registration for online suppliers.
• If unavailable, ask the pharmacist for suitable PBS alternatives.
• Plan for rural delays and arrange emergency supply with the prescriber if needed.

Because tofisopam may not be PBS‑listed, cost considerations often influence choice of alternatives.

Registration & Regulation

TGA Approval And ARTG Checks

Before supply, clinicians and pharmacists should verify current TGA ARTG registration.

International brands such as Grandaxin are marketed in Europe and Toficalm is marketed in India, but local authorisation for each brand in Australia is not specified in the provided data.

PBS Subsidy And Reporting

Check the PBS website for current subsidy status; if not listed, patients pay private price.

Report adverse drug reactions to the TGA via the Adverse Event Reporting system and use local pharmacovigilance channels.

• Checklist For Regulatory Action:
• Check ARTG for current registrations.
• Check PBS for subsidy listings.
• Document supply in patient records.
• Report suspected ADRs to the TGA.

Advise patients regarding TGA rules on personal importation and lawful pathways for obtaining overseas medicines.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

How should patients store tablets at home in Australia?

Store below 25°C and protect from moisture.

Keep tablets in the original blister until use and avoid storing in bathrooms or cars where heat and humidity levels can exceed recommended conditions.

Pharmacy Cold‑Chain And Transport Considerations

While not generally a cold‑chain medicine, stock should be transported and stored in climate‑controlled conditions to avoid degradation.

• Pharmacy Checklist:
• Monitor storage temperatures and keep stock in original packaging.
• Maintain lot and expiry records.
• Have an emergency relocation plan for heatwaves or transport delays.

Provide patients with a small printed storage card when dispensing to reinforce correct storage at home.

Guidelines For Proper Use & Pharmacist Counselling

Australian Pharmacist Counselling Style (Brief Script)

What to say in a concise pharmacy consultation.

Explain the purpose: it is an anxiolytic that often causes less sedation than some benzodiazepines but may still make you drowsy.

Explain expected onset and the usual dosing schedule as prescribed.

Warn against alcohol and other sedatives and explain common side effects to watch for.

Stress the importance of short‑term use (commonly 2–6 weeks) and schedule follow‑up within 1–2 weeks to review effectiveness and side effects.

Provide a written action plan and advise the patient to contact the prescriber if benefit is limited or side effects occur.

Patient Advice From PBS And National Health Authorities

Reinforce that a lawful prescription is required and that adverse events should be reported to the TGA.

• Safety Monitoring Checklist:
• Watch for sedation, falls and mood changes.
• Look for signs of misuse or escalating doses without consultation.
• Check hepatic and renal function where clinically indicated.

Provide patient information leaflets, an adherence checklist and obtain documented consent for any off‑label use.

Delivery Across Australia